Advertisement
Advertisement

KURA

KURA logo

Kura Oncology, Inc.

10.36
USD
Sponsored
-0.03
-0.29%
Jul 27, 15:50 UTC -4
Open

Kura Oncology, Inc. Profile

About

Kura Oncology, Inc. is a biopharmaceutical company. The company is involved in the discovery and development of therapeutics for the treatment of tumors and blood cancers. Its product pipeline includes small molecule drug candidates which are in different clinical trial consists of Tipifarnib-HRAS, Tipifarnib-PTCL, ERK inhibitor program and Menin MLL inhibitor program. Kura Oncology, Inc. is headquartered in La Jolla, California.

Info & Links

CEO

Troy E. Wilson

Headquarters

4930 DIRECTORS PLACE, SUITE 500
SAN DIEGO, CA 92121, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.kuraoncology.com

Auditor

Ernst & Young LLP

Share holders

98

Employees

260

Kura Oncology, Inc. Statistics

Valuation Measures

Market Capitalization2

919.70M

Enterprise Value

890.37M

Enterprise Value/EBITDA(ttm)

-2.75

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

11.58

Price to Book(mrq)

4.42

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

99.92%

Operating Margin(ttm)

-412.95%

Profit Margin(ttm)

-416.00%

Return on Equity(ttm)

-102.59%

Return on Invested Capital(ttm)

-110.59%

Return on Assets(ttm)

-39.61%

Income Statement

Revenue(ttm)

71.64M

Revenue Per Share(ttm)

0.81

Gross Profit(ttm)

71.32M

EBITDA(ttm)3

-323.33M

Net Income Available to Common(ttm)

-294.57M

Diluted EPS(ttm)

-3.18

Share Statistics

Beta (5Y Monthly)

0.25

52-Week Change

66.29%

S&P 500 52-Week Change

16.13%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

88.77M

Dividend Yield

0.00%

Float4

82.68M

% Held by Insiders

6.40%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

580.82M

Total Cash Per Share(mrq)

6.54

Total Debt(mrq)

9.75M

Total Debt/Equity(mrq)

5.58%

Current Ratio(mrq)

6.06%

Quick Ratio(mrq)

6.05%

Book Value Per Share(mrq)

1.98

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.73

Free Cash Flow(ytd)

-70.70M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement